Logo do repositório
 
Publicação

Marked immunosuppressive effects of the HIV-2 envelope protein in spite of the lower HIV-2 pathogenicity

dc.contributor.authorCavaleiro, R.
dc.contributor.authorSousa, A. E.
dc.contributor.authorLoureiro, A.
dc.contributor.authorVictorino, R. M.
dc.date.accessioned2015-06-17T10:09:01Z
dc.date.available2015-06-17T10:09:01Z
dc.date.issued2000-12
dc.description© 2000 Lippincott Williams & Wilkinseng
dc.description.abstractObjective: HIV-1 envelope proteins have immunosuppressive properties and it is thought that they have a role in the establishment of immunodeficiency. This study characterizes the immunological effects of HIV-2 envelope protein gp105, a virus which is associated with a slower rate of disease progression. Methods: The effects of recombinant baculovirus-expressed envelope proteins from HIV-IIIB HIV-1MN, HIV-2ROD and SIVmac251 on anti-CD3-stimulated peripheral blood mononuclear cells (PBMC) from healthy donors were evaluated by incorporation of 3H-thymidine, flow cytometric analysis of bromodeoxyuridine incorporation in different T cell subsets, kinetics of expression of costimulatory molecules (CD40L/OX40) and assessment of cell death by annexin V/propidium iodide staining. The effects on production of tumour necrosis factor α (TNF-α) by monocytes were assessed at the single-cell level after a 6 h culture of unstimulated PBMC. Results: HIV-2 gp105 was more inhibitory than HIV-1 gp120 of T cell proliferation and the upregulation of CD40L and OX40; in the absence of signficant induction of apoptosis. This inhibition affected both CD4 and CD8 T cells and was only partially reversed by costimulation with interleukin 2 or CD28. gp105 strongly inducted TNF-α production by monocytes. Conclusion: The immunosuppressive properties of the HIV envelope proteins could be beneficial rather than detrimental to the host by interfering with the heightened state of immunocellular activation that characterizes HIV infection and by limiting the bursts of viral replication. This hypothesis could in part explain the slower decline of CD4 cell numbers in HIV-2 infection and deserves further exploration.eng
dc.description.sponsorshipThis study was supported by grants from Fundaçãoo para a Ciência e Tecnologia - Ministério da Ciência and from Comissão Nacional de Luta Contra a SIDA (CNLCS) - Ministério da Saúde (Portugal) to RMMV. RC, AL and AES received scholarships from Fundação para a Ciência e Tecnologia - PRAXIS XXI.eng
dc.identifier.citationAIDS 2000, 14: 2679-2686por
dc.identifier.issn0269-9370
dc.identifier.urihttp://journals.lww.com/aidsonline/Fulltext/2000/12010/Marked_immunosuppressive_effects_of_the_HIV_2.7.aspx
dc.identifier.urihttp://hdl.handle.net/10451/18292
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherLippincott Williams &Wilkinseng
dc.relation.publisherversionThe definitive version is available at http://journals.lww.com/pages/default.aspxpor
dc.subjectHIV-2eng
dc.subjectHIV-1eng
dc.subjectHIV envelope proteinseng
dc.subjectCD40Leng
dc.subjectOX40eng
dc.titleMarked immunosuppressive effects of the HIV-2 envelope protein in spite of the lower HIV-2 pathogenicityeng
dc.typejournal article
dspace.entity.typePublication
oaire.citation.titleAIDS: Official Journal of the International Aids Societyeng
rcaap.rightsclosedAccesspor
rcaap.typearticlepor

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
Marked_immunosuppressive.pdf
Tamanho:
231.97 KB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.2 KB
Formato:
Item-specific license agreed upon to submission
Descrição: